MedTrace Logo

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-03-17

No results posted yet for this study

Summary

With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Praphan Phanuphak, MD, PhD · HIV-NAT, Thai Red Cross AIDS Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00411983 on ClinicalTrials.gov